More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$25.00B
EPS
8.43
P/E ratio
26.2
Price to sales
3.46
Dividend yield
1.072%
Beta
0.865011
Previous close
$261.91
Today's open
$259.32
Day's range
$256.88 - $262.50
52 week range
$195.14 - $269.44
CEO
Daniel A. Carestio
Employees
17937
Headquarters
Dublin 2,
Exchange
New York Stock Exchange
Shares outstanding
97107020
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Dividend Champion, Contender, And Challenger Highlights: Week Of November 15
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Seeking Alpha • Nov 13, 2026

What STERIS (STE) Said on Its Q2 Earnings Call
STERIS NYSE: STE raised its fiscal 2027 earnings outlook after reporting higher second-quarter revenue and profit, as tariff refunds helped expand margins and strong Life Sciences equipment shipments offset a slower start to the year in its sterilization business.
MarketBeat • Nov 7, 2026

STERIS plc (STE) Q2 2027 Earnings Call Transcript
STERIS plc ( STE ) Q2 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Julie Winter - Vice President of Investor Relations & Corporate Communications Karen Burton - Senior VP, CFO & Chief Accounting Officer Daniel Carestio - President, CEO & Director Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Patrick Andrew Wood - UBS Investment Bank, Research Division Steven Etoch - Stephens Inc., Research Division Michael Polark - Wolfe Research, LLC Michael Matson - Needham & Company, LLC, Research Division Jason Bednar - Piper Sandler & Co., Research Division Presentation Operator Good day, and welcome to the STERIS plc Second Quarter 2027 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Seeking Alpha • Nov 5, 2026

STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up
STERIS beats Q2 fiscal 2027 earnings and revenue estimates, fueled by strong segment growth and margin gains, and raises its full-year adjusted EPS outlook.
Zacks Investment Research • Nov 5, 2026

STERIS Announces Financial Results for Fiscal 2027 Second Quarter
DUBLIN, IRELAND, Nov. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 second quarter ended September 30, 2026. Total revenue for the second quarter of fiscal 2027 increased 9% to $1.6 billion compared with $1.5 billion in the second quarter of fiscal 2026. Constant currency organic revenue growth was 8% in the second quarter.
GlobeNewsWire • Nov 4, 2026

Steris (STE) Q2 Earnings and Revenues Surpass Estimates
Steris (STE) came out with quarterly earnings of $2.94 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.47 per share a year ago.
Zacks Investment Research • Nov 4, 2026

Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Investment Research • Nov 5, 2026

STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?
STE's second-quarter fiscal 2027 earnings may benefit from Healthcare growth, recent acquisitions, easing AST comparisons and continued margin expansion.
Zacks Investment Research • Oct 30, 2026

2 Healthcare Technology Stocks for a Digital Health Boom
GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
Zacks Investment Research • Oct 29, 2026

STERIS Announces Dividend of $0.69 per share
DUBLIN, IRELAND, Oct. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.69 per share. The dividend is payable on December 17, 2026, to shareholders of record at the close of business on November 17, 2026.
GlobeNewsWire • Oct 28, 2026

¹ Disclosures

Open an M1 investment account to buy and sell STERIS plc (Ireland) commission-free¹. Build wealth for the long term using automated trading and transfers.